Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Nov;44(5):733–740. doi: 10.1038/bjc.1981.260

Flurbiprofen, a non-steroid anti-inflammatory agent, protects cells against hypoxic cell radiosensitizers in vitro.

B C Millar, S Jinks, T J Powles
PMCID: PMC2010854  PMID: 7317272

Abstract

Overnight exposure of Chinese hamster cells (V79-753B) to 5 x 10(-5) M flurbiprofen (2-(2-fluoro-4-biphenyl)propionic acid) in vitro reduced the cytotoxic effects of misonidazole, 1-methyl-4-nitro-5-phenoxysulphonylimidazole (NSC 38087) and nitrofurantoin, both in air and in hypoxia at 37 degrees C. Flurbiprofen did not alter the cells' uptake of 14C-misonidazole, nor did it affect the radiosensitivity of aerobic or anaerobic cells, or the degree of hypoxic-cell radiosensitization produced by the sensitizers. When flurbiprofen-treated cells were exposed to melphalan there was no protection against cytotoxicity. These data suggest that flurbiprofen may inhibit the catabolism of radiosensitizers to toxic products and indicate the need to examine whether it will protect against misonidazole-induced toxicity in vivo.

Full text

PDF
733

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biaglow J. E., Jacobson B. Effect of nitrobenzene derivatives on electron transfer in cellular and chemical models. Mol Pharmacol. 1977 Mar;13(2):269–282. [PubMed] [Google Scholar]
  2. Burstein S., Gagnon G., Hunter S. A., Maudsley D. V. Elevation of prostaglandin and cyclic AMP levels by arachidonic acid in primary epithelial cell cultures of C3H mouse mammary tumors. Prostaglandins. 1977 Jan;13(1):41–53. doi: 10.1016/0090-6980(77)90041-7. [DOI] [PubMed] [Google Scholar]
  3. Cooke B. C., Fielden E. M., Johnson M. Polyfunctional radiosensitizers. I. Effects of a nitroxyl biradical on the survival of mammalian cells in vitro. Radiat Res. 1976 Jan;65(1):152–162. [PubMed] [Google Scholar]
  4. Denekamp J., Harris S. R. Tests of two electron-affinic radiosensitizers in vivo using regrowth of an experimental carcinoma. Radiat Res. 1975 Feb;61(2):191–203. [PubMed] [Google Scholar]
  5. Dische S., Saunders M. I., Lee M. E., Adams G. E., Flockhart I. R. Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses. Br J Cancer. 1977 May;35(5):567–579. doi: 10.1038/bjc.1977.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hall E. J., Roizin-Towle L. Hypoxic sensitizers: radiobiological studies at the cellular level. Radiology. 1975 Nov;117(2):453–457. doi: 10.1148/117.2.453. [DOI] [PubMed] [Google Scholar]
  7. Mason R. P., Holtzman J. L. The mechanism of microsomal and mitochondrial nitroreductase. Electron spin resonance evidence for nitroaromatic free radical intermediates. Biochemistry. 1975 Apr 22;14(8):1626–1632. doi: 10.1021/bi00679a013. [DOI] [PubMed] [Google Scholar]
  8. McCalla D. R., Kaiser C., Green M. H. Genetics of nitrofurazone resistance in Escherichia coli. J Bacteriol. 1978 Jan;133(1):10–16. doi: 10.1128/jb.133.1.10-16.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. McCalla D. R., Reuvers A., Kaiser C. Breakage of bacterial DNA by nitrofuran derivatives. Cancer Res. 1971 Dec;31(12):2184–2188. [PubMed] [Google Scholar]
  10. Millar B. C., Jinks S. The effect of dexamethasone on the radiation survival response and misonidazole-induced hypoxic-cell cytotoxicity in Chinese hamster cells V-79-753B in vitro. Br J Radiol. 1981 Jun;54(642):505–511. doi: 10.1259/0007-1285-54-642-505. [DOI] [PubMed] [Google Scholar]
  11. Olive P. L., McCalla D. R. Damage to mammalian cell DNA by nitrofurans. Cancer Res. 1975 Mar;35(3):781–784. [PubMed] [Google Scholar]
  12. Raleigh J. A., Shum F. Y., Koziol D. R., Saunders W. M. Structure-function dependence and allopurinol inhibition of radiosensitizer/nitroreductase interaction: approaches to improving therapeutic ratios. Cancer Clin Trials. 1980 Spring;3(1):55–62. [PubMed] [Google Scholar]
  13. Stratford I. J., Williamson C., Hardy C. Cytotoxic properties of a 4-nitroimidazole (NSC 38087): a radiosensitizer of hypoxic cells in vitro. Br J Cancer. 1981 Jul;44(1):109–116. doi: 10.1038/bjc.1981.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Taylor Y. C., Rauth A. M. Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro. Br J Cancer. 1980 Jun;41(6):892–900. doi: 10.1038/bjc.1980.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Trocha P. J., Catravas G. N. Variation in cyclic nucleotide levels and lysosomal enzyme activities in the irradiated rat. Radiat Res. 1980 Sep;83(3):658–667. [PubMed] [Google Scholar]
  16. Urtasun R. C., Band P., Chapman J. D., Rabin H. R., Wilson A. F., Fryer C. G. Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative. Radiology. 1977 Mar;122(3):801–804. doi: 10.1148/122.3.801. [DOI] [PubMed] [Google Scholar]
  17. Varghese A. J., Whitmore G. F. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole. Cancer Res. 1980 Jul;40(7):2165–2169. [PubMed] [Google Scholar]
  18. Wasserman T. H., Phillips T. L., Van Raalte G., Urtasun R., Partington J., Koziol D., Schwade J. G., Gangji D., Strong J. M. The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone. Br J Radiol. 1980 Feb;53(626):172–173. doi: 10.1259/0007-1285-53-626-172. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES